RI.PA (Pernod Ricard SA) — Investment Thesis

Scored 2026-02-24 | Entry price: EUR 86.84 | Composite: 3.4/5 (17/25)

Hypothesis

Pernod Ricard is the world's #2 premium spirits company trading at a 55% drawdown from its 2023 peak due to a China cognac import ban and US spirits destocking. The market prices in only 2.5% growth for a company with a 12.6% dividend CAGR over the past decade. The founding Ricard family — who control 28.7% of shares — are aggressively buying on the open market at current prices. When the family that built the business over 50 years is spending millions of their own money buying shares, they're telling you this is a trough. The thesis is mean-reversion: spirits demand is structurally durable, the headwinds are cyclical, and you're buying a premium franchise at trough-cycle multiples alongside the most informed insiders.

Why This Is Good

The setup

• 5/7 Graham defensive filters passed — moderate P/E (13.5x), moderate P/B (1.41x), blended P/E × P/B = 19.0 (under 22.5 ceiling)
• 55% drawdown from EUR 193 peak — the entire China + US headwind is priced in
• Implied growth priced in: 2.5% — absurdly low for a company targeting 3-6% organic growth
• Beta 0.37 — one of the most defensive stocks in the European market

The conviction signal

• CEO Alexandre Ricard bought shares personally multiple times in 2024-2025
• Société Paul Ricard SA (family vehicle) spent EUR 8.7M+ buying at EUR 87-89 in October 2025
• Director Patricia Barbizet bought EUR 214K in May 2025
• Zero net insider selling by the founding family
• Per framework rule [shr-002]: systematic insider buying by multiple officers/directors is a strong bullish signal — this is the most favorable insider pattern across all 5 stocks screened

The moat

• Irreplaceable aged inventory — EUR 8.4B of scotch, cognac, and Irish whiskey aging in barrels. You cannot replicate 25-year-old Chivas Regal or Martell XO. This is a real physical moat.
• 19 strategic international brands with global distribution — Jameson, Absolut, Chivas, Martell, Ballantine's, Beefeater, Havana Club, Malibu
• Gross margins stable at 59-61% through the entire downturn — pricing power intact
• #2 global position behind only Diageo, trading at a meaningful P/E discount (13.5x vs Diageo 23.7x)

The income

• 5.4% dividend yield — EUR 4.70/share
• 20+ year uninterrupted dividend record (one COVID deferral, fully caught up)
• 12.6% dividend CAGR over 10 years — exceptional for consumer staples

Why Graham Thinks It's Good

1. Adequate size — EUR 21.9B market cap, EUR 11B revenue
2. Earnings stability — profitable every year on record; no loss years even through COVID
3. Dividend record — 20+ years of uninterrupted payments with only one temporary COVID deferral
4. Moderate P/E — 13.5x trailing (under 15x threshold)
5. Moderate P/B — 1.41x (under 1.5x threshold); blended P/E × P/B = 19.0 (under 22.5)
6. Margin of safety — at 3% growth assumption, Graham IV = EUR 93.53, giving 7.7% margin. On normalized peak EPS (EUR 8.81), Graham IV = EUR 127.75, giving 47% margin.

Fails on: current ratio borderline (1.92 vs 2.0 threshold), long-term debt exceeds working capital, and recent earnings have declined (not grown 33% over 10 years in the short window).

Graham's view on temporary setbacks: Graham explicitly identifies "unpopular large companies" as a prime hunting ground for the enterprising investor — blue chips selling at low multiples because of temporary bad news. Pernod fits this pattern exactly: a dominant franchise priced for permanent impairment due to cyclical headwinds.

Why Paleologo Thinks It's Good

1. Kelly criterion shows positive edge — full Kelly 27.1%, half Kelly 13.5%. Edge per EUR risked: +0.329.
2. Extremely low correlation — beta 0.37, consumer defensive sector. Near-zero correlation with tech, financials, or cyclicals. Maximum diversification benefit.
3. Low volatility relative to expected return — the Kelly formula (f* = μ/σ²) rewards this profile with a large allocation precisely because the risk per unit of expected return is favorable.
4. Uncorrelated to AGN.AS — insurance and spirits have minimal fundamental overlap. Holding both positions improves portfolio IR through the breadth term in the Fundamental Law.

Entry Plan

Pre-buy checklist (re-check on purchase day):

• [ ] Price still below EUR 100 (if above, re-run Kelly with updated inputs)
• [ ] Founding family hasn't started selling (check insiderscreener.com for RI.PA)
• [ ] No dividend cut announcement since analysis date
• [ ] Net debt/EBITDA still below 4.5x
• [ ] No major new tariff escalation on EU spirits

Exit Targets

Profit targets (sell in thirds)

Time-based exit

• Re-score at every H1 and FY results (approximately February and August each year)
• Exit if no progress by August 2028 (30 months) — by then, China ban should have resolved and US destocking should be complete. If the stock is still at EUR 85-90 after 2.5 years, the "temporary headwind" thesis was wrong.

Red Flags to Exit

EXIT immediately

• Founding family starts selling — this is the single strongest signal. The Ricard family buying at EUR 87-89 is the core conviction anchor. If they reverse and begin selling, follow them out. They know the business better than any analyst.
• Net debt/EBITDA exceeds 5.0x — at that level the balance sheet is in danger zone for a consumer company. Dividend would be cut, covenant risk rises, and equity value erodes.
• FCF below EUR 800M for two consecutive fiscal years — the dividend (EUR 1.2B) would be structurally unfundable. Exit before the inevitable cut.

RE-SCORE (may lead to exit)

• Dividend cut below EUR 4.00 — signals management has lost confidence in the earnings recovery. Re-score all 5 factors. May still hold at reduced size if the rest of the thesis is intact.
• China cognac ban extends beyond 3 years — the Martell recovery thesis becomes structurally impaired. Reduce position; the moat is still intact in other categories but a major earnings driver is permanently gone.
• Two consecutive earnings misses vs consensus — signals the "trough" call was premature. Re-score.
• US spirits market doesn't stabilize by FY27 — if the -15% organic decline in the US becomes a multi-year trend rather than a cycle, the normalized earnings estimate needs to be revised down.

TRIM to quarter-Kelly

• Any qualitative factor drops below 3/5 on re-scoring
• Gross margins fall below 55% — pricing power erosion would signal structural brand impairment, not just cyclical weakness

NOT a reason to exit

• Price drops 20-30% with unchanged fundamentals — increase position or at minimum hold. If the family is still buying, you should be too.
• One bad quarter in China or US — the thesis already assumes 2-3 years of headwinds. Individual quarters don't change the thesis.
• Short-term currency headwinds — Pernod reports in EUR but earns globally. FX noise is not fundamental.